NASDAQ:MRCC Monroe Capital Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Monroe Capital Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.88 +0.01 (+0.15 %) (As of 09/22/2020 12:00 AM ET) Add Compare Share Today's Range$6.79Now: $6.88▼$7.0050-Day Range$6.22MA: $7.12▼$7.6152-Week Range$3.56Now: $6.88▼$12.10Volume81,399 shsAverage Volume178,764 shsMarket Capitalization$146.57 millionP/E RatioN/ADividend Yield14.56%Beta1.3 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Monroe Capital Corporation is a business development company specializing in senior, unitranche and junior secured debt and to a lesser extent, unsecured debt and equity investments, and buyouts in middle-market companies. The fund prefers to invest in casinos and gaming, broadcasting, publishing, alcoholic beverage and tobacco distribution, oil and gas, insurance, pharmaceuticals and bio sciences, aerospace and defense, commercial printing, natural rubber, glass, container and packaging, metals and mining, and real estate. It focuses to invest in the United States and Canada. The fund focuses on companies with a maximum of $25 million in EBITDA per year.Read More Beat the Market (BTM) Rank™ 2.2 Analyst's Opinion Consensus RatingMonroe Capital has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.50, Monroe Capital has a forecasted upside of 23.5% from its current price of $6.88.Amount of Analyst CoverageMonroe Capital has received no research coverage in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesMonroe Capital has received 345 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMonroe Capital has received 314 “underperform” votes. (Add your “underperform” vote.)Community SentimentMonroe Capital has received 52.35% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Monroe Capital and other stocks. Vote “Outperform” if you believe MRCC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MRCC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipMonroe Capital is a leading dividend payer. It pays a dividend yield of 14.56%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthMonroe Capital has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Monroe Capital is 70.42%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on EPS estimates, Monroe Capital will have a dividend payout ratio of 92.59% in the coming year. This indicates that Monroe Capital may not be able to sustain their current dividend. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Monroe Capital insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.10% of the stock of Monroe Capital is held by insiders.Percentage Held by InstitutionsOnly 19.40% of the stock of Monroe Capital is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Monroe Capital are expected to decrease by -23.94% in the coming year, from $1.42 to $1.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Monroe Capital is -9.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Monroe Capital is -9.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMonroe Capital has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.2Community Rank: 2.6Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.58 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Investment advice Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:MRCC Previous Symbol CUSIPN/A CIK1512931 Webwww.monroebdc.com Phone312-258-8300Debt Debt-to-Equity Ratio1.64 Current Ratio3.44 Quick Ratio3.44Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio4.85 P/E GrowthN/A Sales & Book Value Annual Sales$68.19 million Price / Sales2.15 Cash Flow$1.28 per share Price / Cash Flow5.36 Book Value$12.20 per share Price / Book0.56Profitability EPS (Most Recent Fiscal Year)$1.42 Net Income$19.21 million Net Margins-20.91% Return on Equity14.79% Return on Assets5.36%Miscellaneous EmployeesN/A Outstanding Shares21,304,000Market Cap$146.57 million Next Earnings Date11/4/2020 (Estimated) OptionableOptionable $6.88 +0.01 (+0.15 %) (As of 09/22/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive MRCC News and Ratings via Email Sign-up to receive the latest news and ratings for MRCC and its competitors with MarketBeat's FREE daily newsletter. Monroe Capital (NASDAQ:MRCC) Frequently Asked Questions How has Monroe Capital's stock been impacted by COVID-19? Monroe Capital's stock was trading at $9.27 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MRCC stock has decreased by 25.8% and is now trading at $6.88. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Monroe Capital? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Monroe Capital in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Monroe Capital. When is Monroe Capital's next earnings date? Monroe Capital is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. View our earnings forecast for Monroe Capital. How were Monroe Capital's earnings last quarter? Monroe Capital Corp (NASDAQ:MRCC) announced its earnings results on Wednesday, August, 5th. The financial services provider reported $0.62 EPS for the quarter, beating the consensus estimate of $0.28 by $0.34. The financial services provider earned $20.64 million during the quarter, compared to the consensus estimate of $14.63 million. Monroe Capital had a negative net margin of 20.91% and a positive return on equity of 14.79%. View Monroe Capital's earnings history. How often does Monroe Capital pay dividends? What is the dividend yield for Monroe Capital? Monroe Capital declared a quarterly dividend on Friday, September 4th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.25 per share on Wednesday, September 30th. This represents a $1.00 annualized dividend and a yield of 14.53%. The ex-dividend date is Tuesday, September 15th. View Monroe Capital's dividend history. What price target have analysts set for MRCC? 3 brokerages have issued 12-month target prices for Monroe Capital's stock. Their forecasts range from $7.00 to $10.00. On average, they anticipate Monroe Capital's stock price to reach $8.50 in the next twelve months. This suggests a possible upside of 23.5% from the stock's current price. View analysts' price targets for Monroe Capital. Are investors shorting Monroe Capital? Monroe Capital saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 104,000 shares, a drop of 11.5% from the August 15th total of 117,500 shares. Based on an average trading volume of 120,400 shares, the short-interest ratio is presently 0.9 days. Currently, 0.5% of the company's shares are sold short. View Monroe Capital's Short Interest. Who are some of Monroe Capital's key competitors? Some companies that are related to Monroe Capital include Och-Ziff Capital Management Group (OZM), Diamond Hill Investment Group (DHIL), Barings BDC (BBDC), Pzena Investment Management (PZN), CF Finance Acquisition (CFFA), PUYI INC/ADR (PUYI), Value Line (VALU), Fidus Investment (FDUS), Saratoga Investment (SAR), Silvercrest Asset Management Group (SAMG), StoneCastle Financial (BANX), Dundee (DDEJF), Westwood Holdings Group (WHG), Great Elm Capital (GECC) and Manning and Napier (MN). View all competitors. What other stocks do shareholders of Monroe Capital own? Based on aggregate information from My MarketBeat watchlists, some companies that other Monroe Capital investors own include Energy Transfer LP Unit (ET), New Residential Investment (NRZ), Intelsat (I), ANNALY CAP MGMT/SH (NLY), Enterprise Products Partners (EPD), Ares Capital (ARCC), AMC Entertainment (AMC), NGL Energy Partners (NGL), Triplepoint Venture Growth BDC (TPVG) and AGNC Investment (AGNC). Who are Monroe Capital's key executives? Monroe Capital's management team includes the following people: Mr. Theodore L. Koenig, Chairman, Pres & CEO (Age 60)Mr. Aaron D. Peck, Chief Investment Officer, CFO & Director (Age 48)Mr. David H. Jacobson, Chief Compliance Officer (Age 58) What is Monroe Capital's stock symbol? Monroe Capital trades on the NASDAQ under the ticker symbol "MRCC." Who are Monroe Capital's major shareholders? Monroe Capital's stock is owned by many different institutional and retail investors. Top institutional investors include Blair William & Co. IL (4.36%), Cliffwater LLC (2.73%), Advisor Group Holdings Inc. (1.89%), Two Sigma Advisers LP (1.06%), Commonwealth Equity Services LLC (0.74%) and Mckinley Capital Management LLC Delaware (0.57%). Company insiders that own Monroe Capital stock include Aaron Daniel Peck, Jeffrey D Steele, Robert S Rubin and Theodore L Koenig. View institutional ownership trends for Monroe Capital. Which institutional investors are selling Monroe Capital stock? MRCC stock was sold by a variety of institutional investors in the last quarter, including Virtus ETF Advisers LLC, Advisors Asset Management Inc., Bridgeway Capital Management Inc., Claybrook Capital LLC, Janney Montgomery Scott LLC, Stephens Inc. AR, and Chicago Partners Investment Group LLC. View insider buying and selling activity for Monroe Capital. Which institutional investors are buying Monroe Capital stock? MRCC stock was bought by a variety of institutional investors in the last quarter, including Cliffwater LLC, Two Sigma Advisers LP, Advisor Group Holdings Inc., Balentine LLC, Blair William & Co. IL, California Public Employees Retirement System, UBS Group AG, and Dorsey & Whitney Trust CO LLC. Company insiders that have bought Monroe Capital stock in the last two years include Aaron Daniel Peck, Jeffrey D Steele, Robert S Rubin, and Theodore L Koenig. View insider buying and selling activity for Monroe Capital. How do I buy shares of Monroe Capital? Shares of MRCC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Monroe Capital's stock price today? One share of MRCC stock can currently be purchased for approximately $6.88. How big of a company is Monroe Capital? Monroe Capital has a market capitalization of $146.57 million and generates $68.19 million in revenue each year. The financial services provider earns $19.21 million in net income (profit) each year or $1.42 on an earnings per share basis. What is Monroe Capital's official website? The official website for Monroe Capital is www.monroebdc.com. How can I contact Monroe Capital? Monroe Capital's mailing address is 311 SOUTH WACKER DRIVE SUITE 6400, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-258-8300 or via email at [email protected] This page was last updated on 9/22/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
